Replacing Inpatient Care by Outpatient Care in the Treatment of Deep Venous Thrombosis – An Economic Evaluation
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Summary: Two clinical trials in patients with acute deep venous thrombosis have indicated that the outpatient management with fixed-dose, subcutaneous low-molecular-weight heparin is at least as effective and safe as inpatient treatment with unfractionated intravenous heparin with respect to recurrent venous thromboembolism and major bleeding. We performed an economic evaluation alongside one of these trials to assess the cost consequences of the outpatient management strategy. Data were collected through case record forms, complemented by a prospective questionnaire in 78 consecutive patients, interviews with health care providers, and hospital data bases. Our study demonstrated that seventy-five percent of patients allocated to low-molecular-weight heparin received treatment either entirely at home or after a brief hospital stay. Fifteen percent of these patients required professional domiciliary care. Within-centre comparisons of resource utilisation in terms of natural units showed that outpatient management with low-molecular-weight heparin reduced the average number of hospital days in the initial treatment period in nine centres by 59 percent (95% CI: 43 to 71 percent) accompanied by a limited increase in outpatient and professional domiciliary care. The average reduction in hospital days at the end of follow up was 40 percent (95% CI: 25 to 54 percent). A cost-minimisation analysis, focusing on resource utilisation directly related to the treatment of deep venous thrombosis and associated costs in one centre demonstrated a cost reduction of 64 percent (95% CI: 56 to 72 percent) with the outpatient management with low-molecular-weight heparin. These data suggest that outpatient management of patients with proximal venous thrombosis using low-molecular-weight heparin reduces resource utilisation and total treatment cost. Implementation should be preceded by a cautious evaluation of a potential cost shifting and organisational prerequisites.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“All reports showed that home management is cost saving compared with inpatient management”
From American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism (2020) · cites this paper as [40]
Citations
Cites
Levine, M., Gent, M., Hirsh, J., Leclerc, J., Anderson, D., Weitz, J., Ginsberg, J., Turpie, A. G., Demers, C., Kovacs, M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341101 · Cited by 1,192
Koopman, M. M. W., Prandoni, P., Piovella, F., Ockelford, P. A., Brandjes, D. P. M., van der Meer, J., Gallus, A. S., Simonneau, G., Chesterman, C. H., Prins, M. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341102 · Cited by 1,111 · cited 4×
“Outpatient treatment with fixed-dose subcutaneous low-molecularweight heparin has been shown to be an effective and safe alternative to inpatient treatment with intravenous adjusted-dose unfractionated heparin for outpatients with proximal deep venous thrombosis (6, 7).”
BackgroundMethodResultSelf-citationProbabilistic Sensitivity Analysis Using Monte Carlo Simulation: A Practical Approach
Doubilet, P., Begg, C. B., Weinstein, M. C., Braun, P., & McNeil, B. J. (1985) · Medical Decision Making · doi:10.1177/0272989x8500500205 · Cited by 860 · cited 1×
“A probabilistic multiway sensitivity analysis was performed to test the robustness of the results to plausible changes in key variables (12).”
MethodHull, R. D., Raskob, G. E., Pineo, G. F., Green, D., Trowbridge, A. A., Elliott, C. G., Lerner, R. G., Hall, J., Sparling, T., Brettell, H. R., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204093261502 · Cited by 700
Prandoni, P., Carta, M., Cogo, A., Ruol, A., Vigo, M., Casara, D., Lensing, A. W. A., Büller, H. R., & ten Cate, J. W. (1992) · The Lancet · doi:10.1016/0140-6736(92)91054-c · Cited by 583 · cited 1×
“Clinical studies have indicated that treatment with fixed-dose, subcutaneous low-molecular-weight heparin is at least as effective and safe as unfractionated intravenous heparin in hospitalised patients with deep venous thrombosis (1-5).”
BackgroundEconomic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues
Drummond, M. F., & Davies, L. (1991) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300007121 · Cited by 337 · cited 1×
“Within-centre comparisons were made of average resource utilisation in both groups in terms of natural units (9).”
BackgroundTreatment of Deep Venous Thrombosis With Low-Molecular-Weight Heparins: A Meta-analysis
Lensing, A. W. A. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430060059007 · Cited by 285 · cited 1×
“Clinical studies have indicated that treatment with fixed-dose, subcutaneous low-molecular-weight heparin is at least as effective and safe as unfractionated intravenous heparin in hospitalised patients with deep venous thrombosis (1-5).”
BackgroundSelf-citationLindmarker, P., Holmström, M., Granqvist, S., Johnsson, H., & Lockner, D. (1994) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648836 · Cited by 210 · cited 1×
“Clinical studies have indicated that treatment with fixed-dose, subcutaneous low-molecular-weight heparin is at least as effective and safe as unfractionated intravenous heparin in hospitalised patients with deep venous thrombosis (1-5).”
BackgroundLopaciuk, S., Meissner, A. J., Filipecki, S., Zawilska, K., Sowier, J., Ciesielski, L., Bielawiec, M., Glowinski, S., & Czestochowska, E. (1992) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656309 · Cited by 146 · cited 1×
“Clinical studies have indicated that treatment with fixed-dose, subcutaneous low-molecular-weight heparin is at least as effective and safe as unfractionated intravenous heparin in hospitalised patients with deep venous thrombosis (1-5).”
BackgroundMorgan, M., & Beech, R. (1990) · Journal of Epidemiology and Community Health · doi:10.1136/jech.44.2.90 · Cited by 105 · cited 1×
“This has been referred to as the “efficiency trap” (13).”
Background
Cited by
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
Antithrombotic Therapy for Venous Thromboembolic Disease
Hyers, T. M., Agnelli, G., Hull, R. D., Morris, T. A., Samama, M., Tapson, V., & Weg, J. G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.176s · Cited by 2,042
Ortel, T. L., Neumann, I., Ageno, W., Beyth, R., Clark, N. P., Cuker, A., Hutten, B. A., Jaff, M. R., Manja, V., Schulman, S., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001830 · Cited by 1,489
van Dongen, C. J., van den Belt, A. G., Prins, M. H., & Lensing, A. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001100.pub2 · Cited by 433
Self-citation
Metadata
- Authors
- van den Belt, A., Prins, M., Gallus, A., Büller, H., Bossuyt, P., & for the TASMAN Study Group
- Affiliations
- University of Amsterdam (NL)
- Flinders Medical Centre (AU)
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 1998
- Volume
- 79
- Issue
- 02
- Pages
- 259-263
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W1782024978
- Cited by
- 90
- References
- 13
- Citations by year
- 2021: 1 · 2020: 2 · 2019: 1 · 2018: 1 · 2017: 2 · 2016: 1 · 2015: 4 · 2013: 1 · 2012: 2
- FWCI
- 10.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Thrombosis and Haemostasis (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Funders
- Sanofi Winthrop
- Topics
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- deep vein thrombosis, outpatient management, low molecular weight heparin, subcutaneous anticoagulation, inpatient care, length of hospital stay, resource utilization (health care), treatment costs, cost minimization, venous thromboembolism, home care, cost shifting
- MeSH terms
- Administration, Cutaneous, Ambulatory Care, Anticoagulants, Clinical Trials as Topic, Costs and Cost Analysis, Evaluation Studies as Topic, Heparin, Heparin, Low-Molecular-Weight, Humans, Infusions, Intravenous, Thrombophlebitis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Replacing Inpatient Care by Outpatient Care in the Treatment of Deep Venous Thrombosis – An Economic Evaluation. https://app.cochat.ai/papers/10.1055/s-0037-1614975
- The paper
- van den Belt, A., Prins, M., Gallus, A., Büller, H., Bossuyt, P., & for the TASMAN Study Group. (1998). Replacing Inpatient Care by Outpatient Care in the Treatment of Deep Venous Thrombosis – An Economic Evaluation. Thrombosis and Haemostasis. https://doi.org/10.1055/s-0037-1614975
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.